NCT00711308 - Tinzaparin in the Treatment of the Acute Pulmonary Embolism | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions

Acute Pulmonary Embolism

Interventions

DRUG

tinzaparin

tinzaparin (innohep®)subcutaneously in a fixed dose of 175 IU anti-Xa/kg of body weight once daily for 6 months

DRUG

acenocoumarol

acenocoumarol for 6 months

Trial Locations (4)

Pneumology Service. Hospital Clínico, Santiago de Compostela

Pneumology Service, Lugo

Pneumology Service. Hospital Xeral Cies, Vigo

Pneumology Service. Hospital do Meixoeiro, Vigo